GHK is a naturally occurring tripeptide (Gly-His-Lys) first isolated from human plasma by Loren Pickart in 1973. Its copper-bound form, GHK-Cu, exhibits a remarkable affinity for fibroblast surface receptors and triggers a cascade of extracellular matrix (ECM) remodelling effects. Plasma GHK concentrations decline with age — from roughly 200 ng/mL at age 20 to 80 ng/mL by age 60 — which framed early research interest in supplementing the peptide back into wound and dermal models.
For UAE researchers, GHK-Cu sits in a different category from systemic peptides such as retatrutide or tesamorelin. It is a topical and locally administered research tool focused on connective tissue, hair follicle dermal papilla, and wound bed biology. The most cited mechanistic paper remains Maquart 1988 — and every subsequent collagen synthesis study traces back to that foundation.
Maquart, Pickart, Laurent, et al. published their seminal in vitro work in FEBS Letters (1988), demonstrating that GHK-Cu at concentrations between 10⁻⁹ M and 10⁻⁷ M significantly stimulated collagen biosynthesis in cultured human dermal fibroblasts. The team used [³H]-proline incorporation as the readout — a standard collagen synthesis assay — and reported peak stimulation of 70% over control at 10⁻⁹ M (1 nM).
A follow-up by the same group (Maquart 1993) extended the findings to glycosaminoglycan synthesis and matrix metalloproteinase modulation. The pattern that emerged is now textbook:
Decorin is a small proteoglycan that decorates collagen fibrils at the d-period gap zone. Its role is to control the lateral fibril diameter and lock collagen into ordered, mature bundles rather than thin, disorganised fibres. Siméon, Wegrowski, Maquart, et al. (1999, 2000) showed that GHK-Cu treatment of dermal fibroblasts increases decorin mRNA expression 2–4 fold and decorin protein secretion in matching proportion.
Why this matters for collagen research:
The pathway logic — GHK-Cu binds fibroblast receptors → activates SMAD-independent TGF-β-adjacent signalling → upregulates decorin and lysyl oxidase → produces mature, organised type I collagen — explains why the peptide outperforms simple copper salts and free GHK in side-by-side fibroblast assays.
Healthy adult dermis is roughly 80% type I collagen and 15% type III collagen. Fetal skin and early wound granulation tissue invert that ratio toward type III, which produces the soft, pliable, but mechanically weaker matrix. Mature wound healing involves a coordinated switch from type III to type I as the tissue remodels over weeks to months.
| Model | Type I collagen response | Type III collagen response | I:III ratio shift |
|---|---|---|---|
| Maquart 1988 fibroblast culture | +70% at 1 nM | +25% at 1 nM | Toward type I |
| Siméon 1999 dermal model | Increased (decorin co-induction) | Modestly increased | Toward type I |
| Pickart 2015 review meta-analysis | Consistent upregulation | Variable, context-dependent | Toward mature type I matrix |
| Free copper sulfate control | No effect | No effect | Unchanged |
The implication: GHK-Cu does not simply pile on collagen. It biases the matrix toward the mature, organised type I phenotype — which is why hair follicle, post-procedure, and aged-skin research models consistently report functional improvements rather than fibrotic mass.
The single most common mistake in GHK-Cu research design is concentration creep. Many researchers assume linear dose-response and push concentrations into the high micromolar range, expecting bigger effects. The literature is consistent that this collapses the response.
| GHK-Cu concentration | Collagen synthesis response (fibroblast culture) | Notes |
|---|---|---|
| 0.1 nM (10⁻¹⁰ M) | +10% over control | Threshold |
| 1 nM (10⁻⁹ M) | +70% over control | Peak (Maquart 1988) |
| 10 nM (10⁻⁸ M) | +60% over control | Plateau |
| 100 nM (10⁻⁷ M) | +40% over control | Declining |
| 1 µM (10⁻⁶ M) | +15% over control | Near baseline |
| 10 µM (10⁻⁵ M) | 0% or negative | Inhibitory zone |
| 100 µM+ (10⁻⁴ M+) | Cytotoxic in long cultures | Avoid |
For topical research formulations, the equivalent concentrations land in the 0.05% to 0.2% range (w/v) — which is what the Leyden et al. clinical work on facial photodamage used. Higher topical concentrations do not produce proportionally better outcomes and may trigger local irritation.
GHK-Cu is hygroscopic and copper-sensitive. The peptide must be lyophilised under inert atmosphere and shipped cold to preserve copper coordination integrity — particularly relevant in the UAE where ambient temperatures during summer months exceed 45°C. REVIVE Peptides operates from a Dubai facility with on-shelf GHK-Cu 50 mg and 100 mg vials and a logistics network that respects cold-chain requirements end-to-end.
| Emirate | Delivery timeline | Cut-off for same/next day | Cold-chain method |
|---|---|---|---|
| Dubai | Same-day | Order by 2:00 PM | Insulated courier, gel packs |
| Abu Dhabi | Next-day | Order by 5:00 PM | Overnight cold courier |
| Sharjah | Same-day or next-day | Order by 12:00 PM (same-day) | Insulated courier |
| Ajman | Next-day | Order by 5:00 PM | Overnight cold courier |
| Ras Al Khaimah | 1–2 days | Order by 3:00 PM | Overnight cold courier |
| Fujairah / UAQ | 1–2 days | Order by 3:00 PM | Overnight cold courier |
Ordering process for UAE researchers:
For broader UAE peptide availability and emirate-by-emirate sourcing notes, see our UAE peptide stock page.
Lyophilised GHK-Cu in a sealed vial is stable at room temperature for transit windows but should be refrigerated at 2–8°C on arrival. Once reconstituted with bacteriostatic water, the solution retains potency for approximately 28 days refrigerated. UAE-specific notes:
Companion reading: BPC-157 reconstitution and storage covers identical cold-chain logic applicable to all REVIVE peptides.
Beyond classical collagen synthesis, the GHK-Cu literature has expanded into gene-expression profiling, hair follicle dermal papilla research, and wound-bed angiogenesis. Pickart and Margolina's 2018 Oxidative Medicine and Cellular Longevity review compiled transcriptomic data showing GHK modulates over 4,000 human genes — including pathways governing DNA repair, anti-inflammatory cytokines, and stem cell signalling.
For UAE-based researchers integrating GHK-Cu into multi-peptide protocols, the natural companions are:
All of these are available in the REVIVE Dubai catalogue with the same 24h delivery commitment across the UAE.
REVIVE Peptides stocks GHK-Cu 50 mg and 100 mg vials in Dubai with same-day delivery across Dubai, next-day to Abu Dhabi and Sharjah, and 1–2 day delivery to the Northern Emirates. Order before the cut-off times listed in the delivery table above.
Maquart 1988 demonstrated peak stimulation at 1 nM (10⁻⁹ M) GHK-Cu, with a plateau through 10 nM and declining response above 100 nM. The dose-response is biphasic — concentrations above 10 µM are inhibitory or cytotoxic.
GHK-Cu binds fibroblast surface receptors, activates intracellular signalling that increases decorin mRNA 2–4 fold, and produces a matching rise in secreted decorin protein. Decorin then sequesters TGF-β1 and organises type I collagen fibrillogenesis — a key reason GHK-Cu produces mature matrix rather than fibrotic scarring.
Approximately 28 days when stored at 2–8°C in a refrigerator. Never expose reconstituted vials to UAE summer heat outside cold storage — copper coordination breaks down rapidly above 30°C and faster under UV light.